BT062, an Antibody-Drug Conjugate Directed Against CD138, Given Weekly for 3 Weeks in Each 4 Week Cycle: Safety and Further Evidence of Clinical Activity
Heffner, Leonard T, Jagannath, Sundar, Zimmerman, Todd M, Lee, Kelvin P, Rosenblatt, Jacalyn, Lonial, Sagar, Lutz, Robert J., Czeloth, Niklas, Osterroth, Frank, Ruehle, Markus, Beelitz, Michelle A., Wartenberg-Demand, Andrea, Haeder, Thomas, Anderson, Kenneth C., Munshi, Nikhil C.
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma
Jagannath, Sundar, Heffner, Leonard T., Ailawadhi, Sikander, Munshi, Nikhil C., Zimmerman, Todd M., Rosenblatt, Jacalyn, Lonial, Sagar, Chanan-Khan, Asher, Ruehle, Markus, Rharbaoui, Faiza, Haeder, Thomas, Wartenberg-Demand, Andrea, Anderson, Kenneth C.
Published in Clinical lymphoma, myeloma and leukemia (01.06.2019)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2019)
Get full text
Journal Article
The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial
Singer, Mervyn, Torres, Antoni, Heinz, Corina C, Weissmüller, Sabrina, Staus, Alexander, Kistner, Steffen, Jakubczyk, Ksenia, Häder, Thomas, Langohr, Patrick, Wartenberg-Demand, Andrea, Schüttrumpf, Jörg, Vincent, Jean-Louis, Welte, Tobias
Published in Critical care (London, England) (09.11.2023)
Published in Critical care (London, England) (09.11.2023)
Get full text
Journal Article
Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models
Schönfeld, Kurt, Herbener, Peter, Zuber, Chantal, Häder, Thomas, Bernöster, Katrin, Uherek, Christoph, Schüttrumpf, Jörg
Published in Pharmaceutical research (01.06.2018)
Published in Pharmaceutical research (01.06.2018)
Get full text
Journal Article
Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID)
Agafina, Alina, Aguiar, Valeria Cristina, Rossovskaya, Maria, Fartoukh, Muriel Sarah, Hajjar, Ludhmila Abrahao, Thiéry, Guillaume, Timsit, Jean-François, Gordeev, Ivan, Protsenko, Denis, Carbone, Javier, Pellegrini, Rita, Stadnik, Claudio Marcel Berdun, Avdeev, Sergey, Ferrer, Miquel, Heinz, Corina C, Häder, Thomas, Langohr, Patrick, Bobenhausen, Iris, Schüttrumpf, Jörg, Staus, Alexander, Ruehle, Markus, Weissmüller, Sabrina, Wartenburg-Demand, Andrea, Torres, Antoni
Published in European journal of medical research (13.08.2024)
Published in European journal of medical research (13.08.2024)
Get full text
Journal Article
Indatuximab Ravtansine (BT062) in Combination with Low-Dose Dexamethasone and Lenalidomide or Pomalidomide: Clinical Activity in Patients with Relapsed / Refractory Multiple Myeloma
Kelly, Kevin R., Siegel, David S., Chanan-Khan, Asher A., Somlo, George, Heffner, Leonard T., Jagannath, Sundar, Zimmerman, Todd, Munshi, Nikhil C, Madan, Sumit, Mohrbacher, Ann, Lonial, Sagar, Barmaki-Rad, Farima, Rühle, Markus, Herrmann, Eva, Wartenberg-Demand, Andrea, Haeder, Thomas, Anderson, Kenneth C.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Indatuximab Ravtansine (BT062) in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma: Clinical Activity in Patients Already Exposed to Lenalidomide and Bortezomib
Kelly, Kevin R., Chanan-Khan, Asher, Heffner, Leonard T, Somlo, George, Siegel, David S., Zimmerman, Todd, Karnad, Anand, Munshi, Nikhil C., Jagannath, Sundar, Greenberg, Allen L., Lonial, Sagar, Roy, Vivek, Ailawadhi, Sikander, Barmaki-Rad, Farima, Chavan, Shailesh, Patel, Pankaj, Wartenberg-Demand, Andrea, Haeder, Thomas, Anderson, Kenneth C
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
Indatuximab Ravtansine (BT062) In Combination With Lenalidomide and Low-Dose Dexamethasone In Patients With Relapsed and/Or Refractory Multiple Myeloma: Clinical Activity In Len/Dex-Refractory Patients
Kelly, Kevin R., Chanan-Khan, Asher, Somlo, George, Heffner, Leonard T, Siegel, David S, Zimmerman, Todd M, Jagannath, Sundar, Munshi, Nikhil C., Lonial, Sagar, Roy, Vivek, Ruehle, Markus, Chavan, Shailesh, Patel, Pankaj, Rothenburger, Markus, Wartenberg-Demand, Andrea, Haeder, Thomas, Anderson, Kenneth C.
Published in Blood (15.11.2013)
Published in Blood (15.11.2013)
Get full text
Journal Article
BT062, a CD138-Specific Immunoconjugate, Demonstrates Superior In Vivo Anti-Myeloma Efficacy In Combination with Lenalidomide or Bortezomib
Zuber, Chantal, Daelken, Benjamin, Aigner, Silke, Haeder, Thomas, Ab, Olga, Whiteman, Kathleen, Hideshima, Teru, Lutz, Robert J, Osterroth, Frank, Uherek, Christoph
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity In a Phase I Study In Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
Jagannath, Sundar, Chanan-Khan, Asher A., Heffner, Leonard T, Avigan, David, Lutz, Robert J, Uherek, Christoph, Osterroth, Frank, Ruehle, Markus, Haeder, Thomas, Niemann, Gabriele, Wartenberg-Demand, Andrea, Munshi, Nikhil C., Anderson, Kenneth C.
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
Jagannath, Sundar, Chanan-Khan, Asher, Heffner, Leonard T., Avigan, David, Zimmerman, Todd M., Lonial, Sagar, Lutz, Robert J., Engling, Andre, Uherek, Christoph, Osterroth, Frank, Ruehle, Markus, Beelitz, Michelle A., Niemann, Gabriele, Wartenberg-Demand, Andrea, Haeder, Thomas, Anderson, Kenneth C., Munshi, Nikhil C.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF
DAELKEN BENJAMIN, UHEREK CHRISTOPH, GERMER MATTHIAS, ZENG STEFFEN, AIGNER SILKE, BRUECHER CHRISTOPH, SCHULZ GREGOR, KRAUS ELMAR, OSTERROTH FRANK, HAEDER THOMAS
Year of Publication 11.03.2016
Get full text
Year of Publication 11.03.2016
Patent
Phase I Study of BT062 Given as Repeated Single Dose Once Every 3 Weeks in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
Chanan-Khan, Asher A., Jagannath, Sundar, Heffner, Leonard T., Avigan, David, Lee, Kelvin P., Lutz, Robert J, Haeder, Thomas, Ruehle, Markus, Uherek, Christoph, Wartenberg-Demand, Andrea Barbara, Munshi, Nikhil, Anderson, Kenneth C.
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
USES OF IMMUNOCONJUGATES TARGETING CD138
BRUECHER CHRISTOPH, NIEMANN GABRIELE, ZUBER CHANTAL, SCHULZ GREGOR, WARTENBERG DEMAND ANDREA, GUTSCHER MARCUS, OSTERROTH FRANK, HAEDER THOMAS, ENGLING ANDRE, KOENIG MARTIN, DAELKEN BENJAMIN, UHEREK CHRISTOPH, BERNOESTER KATRIN
Year of Publication 14.08.2014
Get full text
Year of Publication 14.08.2014
Patent
USES OF IMMUNOCONJUGATES TARGETING CD138
CZELOTH NIKLAS, BRUECHER CHRISTOPH, NIEMANN GABRIELE, ZUBER CHANTAL, WARTENBERG DEMAND ANDREA, SCHULZ GREGOR, OSTERROTH FRANK, ENGLING ANDRE, HAEDER THOMAS, DAELKEN BENJAMIN, UHEREK CHRISTOPH, ZENG STEFFEN, AIGNER SILKE
Year of Publication 11.05.2012
Get full text
Year of Publication 11.05.2012
Patent
USES OF IMMUNOCONJUGATES TARGETING CD138
AINGER SILKE, ANGLING ANDRE, CZELOTH NIKLAS, BRUECHER CHRISTOPH, ZUBER CHANTAL, NIEMANN GABRIELE, SCHULZ GREGOR, OSTERROTH FRANK, HAEDER THOMAS, DAELKEN BENJAMIN, WARTENBERG-DEMAND ANDREA, UHEREK CHRISTOPH, ZENG STEFFEN
Year of Publication 31.07.2019
Get full text
Year of Publication 31.07.2019
Patent
IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF
DAELKEN, BENJAMIN, GERMER, MATTHIAS, ZENG, STEFFEN, UHEREK, CHRISTOPH, HAEDER, THOMAS, AIGNER, SILKE, KRAUS, ELMAR, BRUECHER, CHRISTOPH, SCHULZ, GREGOR, OSTERROTH, FRANK
Year of Publication 05.06.2018
Get full text
Year of Publication 05.06.2018
Patent
USES OF IMMUNOCONJUGATES TARGETING CD138
Zuber, Chantal, Koenig, Martin, Haeder, Thomas, Gutscher, Marcus, Niemann, Gabriele, Daelken, Benjamin, Wartenberg-Demand, Andrea, Osterroth, Frank, Engling, Andre, Schulz, Gregor, Bruecher, Christoph, Uherek, Christoph, Bernoester, Katrin
Year of Publication 25.04.2019
Get full text
Year of Publication 25.04.2019
Patent